HBsAg non-reactive but HBV DNA reactive blood donors in Wuhu area: infection status and tracing results
10.13303/j.cjbt.issn.1004-549x.2023.01.016
- VernacularTitle:芜湖地区HBsAg无反应性/HBV DNA反应性献血者的感染状态及追踪结果分析
- Author:
Jie WU
1
;
Jie PAN
1
;
Guoqing YU
2
;
Ying ZHANG
1
;
Hui HUANG
1
;
Yi MA
1
;
Song YUAN
1
;
Xu YANG
1
Author Information
1. Wuhu Central Blood Station, Wuhu 241000, China
2. Conch Hospital of Anhui Medical University
- Publication Type:Journal Article
- Keywords:
HBV DNA;
individual donor-NAT;
chemiluminescence;
window period infection;
OBI;
follow-up of blood donors
- From:
Chinese Journal of Blood Transfusion
2023;36(1):64-68
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To detect and analyze the infection status of HBsAg non-reactive /HBV DNA reactive blood donors by individual donor-NAT (ID-NAT) and chemiluminescence technology, and to explore the feasibility and potential risks of reentry. 【Methods】 The blood screening results of blood donors in Wuhu from January 2018 to October 2021 were queried by blood station information management software. The blood donation information of all HBsAg non-reactive /HBV DNA reactive blood donors was collected and then recalled by telephone. After informed consent, samples were taken for HBV DNA nucleic acid single test, enzyme-linked immunoassay for HBsAg, chemiluminescence assay for HBV seromarkers(including HBsAg, anti-HBs, HBeAg, anti-HBe and anti-HBc), and alanine aminotransferase (ALT) test. All the results were statistically analyzed. 【Results】 From January 2018 to October 2021, there were 142 051 donations, and the positive rate of sole HBV DNA was 0.06% (91/142 051), and 33 people (37 person-times) were successfully followed up. The yield rates of HBsAg, anti-HBs and anti-HBc were 6.06% (2/33), 39.39% (13/33) and 96.97% (32/33), respectively; None HBeAg was yielded. After two times of ID-NAT, 8 patients remained non-reactive to both systems, with a negative conversion rate of 24.24% (8/33). Meanwhile, 25 patients were at least once reactive to ID-NAT, and 23 of them were occult HBV infection with serologically reactivity. There were 2(6.25%) patients with HBsAg positive conversion and HBV DNA persistent reactivity, which were window period infection. One person was confirmed as false reactivity (no HBV infection) as he remained unreactive to both repeated ID-NAT and serological tests. 【Conclusion】 Chemiluminescence assay is more sensitive than ELISA in detecting HBV serum markers, which is beneficial to early detection of HBV samples in window period. The yielding rate of anti-HBc among HBsAg non-reactive/HBV DNA reactive blood donors detected by blood screening in this region is very high, and most of them are occulting infection, so the ID-NAT should be no less than 2 times in the reentry strategy.
